JADPRO CE
MULTIPLE MYELOMA AND PLASMA CELL DISORDERS: UPDATE ON DIAGNOSIS, PROGNOSIS, TREATMENT, AND SUPPORTIVE CARE
This supplement to JADPRO has been developed by members of the International Myeloma Foundation (IMF) Nurse Leadership Board.
GUEST EDITORS
Beth Faiman, PhD, MSN, APRN-BC, AOCN, BMTCN, FAAN, FAPO
Cleveland Clinic Taussig Cancer Insitute
Tiffany Richards, PhD, ANP-BC, AOCNP
The University of Texas MD Anderson Cancer Center
Available Till: 07/01/2023
Estimated time to complete: 2.5 hours
This certified activity is supported by educational grants from AbbVie, Inc.; Bristol-Myers Squibb Company; GlaxoSmithKline; Janssen Biotech, Inc., administered by Janssen Scientific Affairs, LLC; Karyopharm Therapeutics; Legend Biotech; Oncopeptides, Inc.; Sanofi Genzyme; and Takeda Pharmaceuticals U.S.A., Inc.
Continuing Education
Continuing Education Information: Multiple Myeloma and Plasma Cell Disorders: Update on Diagnosis, Prognosis, Treatment, and Supportive Care
Editorial
Introduction
Beth Faiman, PhD, MSN, APRN-BC, AOCN®, BMTCN, FAAN, FAPO, and Tiffany Richards, PhD, ANP-BC, AOCNP®
Grand Rounds
A Focus on Newly Diagnosed Multiple Myeloma
Kevin Brigle,(1) PhD, ANP, Daniel Verina,(2) DNP, RN, ACNP-BC, and Beth Faiman,(3) PhD, MSN, APRN-BC, AOCN®, BMTCN, FAAN, FAPO
Grand Rounds
A Focus on Relapsed Multiple Myeloma
Kimberly Noonan,(1) DNP, ANP-BC, AOCN®, Sandra Rome,(2) RN, MN, AOCN®, CNS, and Beth Faiman,(3) PhD, MSN, APRN-BC, AOCN®, BMTCN, FAAN, FAPO
Grand Rounds
A Focus on Special Populations in Relapsed Multiple Myeloma
Mary Steinbach,(1) DNP, APRN, Kathleen Colson,(2) RN, BSN, BS, and Beth Faiman,(3) PhD, MSN, APRN-BC, AOCN®, BMTCN, FAAN, FAPO
Grand Rounds
A Focus on CAR T-Cell Therapy and Bispecific Antibodies in Multiple Myeloma
Donna Catamero, ANP-BC, OCN®, CCRC, Tiffany Richards, PhD, ANP-BC, AOCNP®, and Beth Faiman,(3) PhD, MSN, APRN-BC, AOCN®, BMTCN, FAAN, FAPO
Grand Rounds
A Focus on Waldenström Macroglobulinemia and AL Amyloidosis
Rebecca Lu, MS, FNP, and Tiffany Richards, PhD, ANP-BC, AOCNP®
